Search
for
Sort by
Research 421–450 of 1000+
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- Treatment modalities for lymphocytic and neutrophilic scarring alopecia
- Contents
- A systematic review on the treatment of androgenetic alopecia
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Pathomechanisms of immune-mediated alopecia
- Alopecia Areata: An Update on Treatment Options for Children
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Alopecia areata – Current understanding and management
- Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
- A review of Janus kinase inhibitor use in scarring alopecia
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Janus kinase inhibitors for alopecia areata: A narrative review
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Baricitinib: A Review in Severe Alopecia Areata
- Alopecia Areata: Current and Emerging Therapies
- Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Quercetin Promotes Production of Secondary Hair Follicle Stem Cells in Cashmere Goat: A Mechanistic Study
- Intrinsic Modulators of Hair Growth: Roles of Growth Factors, Cytokines, Chemokines, and Interferons
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms